Human Embryonic Stem Cell

Human Embryonic Stem Cell - most related articles:

- US can continue to fund embryonic stem cell research - 12.2
- 2 types of stem cells are similar - 11.8
- US cancer group AACR supports NIH stem cell research - 11.4
- US to continue stem cell research - 11.2
- US Stem Cell Bank has received all 21 cell lines - 10.7
- Stem cell therapy may prove valuable in paralysis - 10.1
- Understanding beginnings of embryonic stem cells helps predict the future - 9.4
- Sickle cell anemia treated with stem cells - 9.1
- Stem cells to create new skin for patients with burns and skin diseases - 8.9
- Stem cell protein LIN28 offers a new cancer target - 8.9

Human Embryonic Stem Cell articles

US can continue to fund embryonic stem cell research
The American Society for Cell Biology (ASCB) applauds the decision of Judge Royce Lamberth of the U.S. District Court for the District of Columbia (DC) to dismiss a lawsuit challenging the U.S. National Institutes of Health guidelines on funding human embryonic stem cell research (hESC).

US company starts clinical trial using stem cells to treat macular degeneration
Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC) announced that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world.

Clinical trial of human embryonic stem cell therapy in US
Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1.

US to continue stem cell research
An appeals court in US allowed the government to resume funding human embryonic stem cell research while the court reviews whether it violates a ban by Congress on spending taxpayer money for experiments.

US cancer group AACR supports NIH stem cell research
The American Association for Cancer Research (AACR), the world's oldest and largest cancer research organization, reiterates its support for the responsible conduct of human embryonic stem cell research that, up until this week, was funded by the National Institutes of Health (NIH) and expresses concern that the recent Federal District Court injunction to block federal funding for human embryonic stem cell research is a setback for scientific discovery.

Embryonic stem cell lines lack genetic diversity
The most widely used human embryonic stem cell lines lack genetic diversity, a finding that raises social justice questions that must be addressed to ensure that all sectors of society benefit from stem cell advances, according to a University of Michigan research team.

Stem cells to create new skin for patients with burns and skin diseases
Researchers has succeeded in recreating a whole epidermis from human embryonic stem cells, revealed in a new study conducted by Marc Peschanski of INSERM published in the Lancet.

Controlled development of stem cells may lead to new stem cell therapies
Investigators at the Burnham Institute for Medical Research (Burnham) and The Scripps Research Institute (TSRI) have made the first comparative, large-scale phosphoproteomic analysis of human embryonic stem cells (hESCs) and their differentiated derivatives.

Human clinical trial of embryonic stem cell therapy approved
Geron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.

US Stem Cell Bank has received all 21 cell lines
The U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden. With the addition of the new lines, the National Stem Cell Bank now has received all 21 cell lines from the six providers listed on the National Institutes of Health (NIH) federal registry.

Stem cell funding for Parkinson's Disease
The Parkinson's Disease Society (PD) has announced funding of £170k to the University of Bristol for research into how to make stem cells produce dopamine and live longer after they have been transplanted into animals.

Stem cells may aid stroke recovery
Neural cells derived from human embryonic stem cells helped repair stroke-related damage in the brains of rats and led to improvements in their physical abilities, according to a new study by researchers at the Stanford University School of Medicine.

Stem cells may improve muscles in muscular dystrophy
Using embryonic stem cells from mice, UT Southwestern Medical Center researchers have prompted the growth of healthy - and more importantly, functioning - muscle cells in mice afflicted with a human model of Duchenne muscular dystrophy. The study represents the first time transplanted embryonic stem cells have been shown to restore function to defective muscles in a model of muscular dystrophy.

13 Human Embryonic Stem Cell articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.93